![]() |
|
|
Vol. 16, Issue 9, 4386-4397, September 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Catenin Signaling Pathway




* Banting and Best Department of Medical Research, University of Toronto, Toronto, Ontario M5G 1L6, Canada;
Department of Biochemistry, University of Toronto, Toronto, Ontario M5G 1L6, Canada
Submitted March 7, 2005;
Revised June 8, 2005;
Accepted June 22, 2005
Monitoring Editor: Asma Nusrat
Cancer metastasis is a multistep process involving many types of cell-cell interactions, but little is known about the adhesive interactions and signaling events during extravasation of cancer cells. Transendothelial migration of cancer cells was investigated using an in vitro assay, in which melanoma cells were seeded on top of a monolayer of endothelial cells. Attachment of melanoma cells on the endothelium induced a twofold increase in N-cadherin expression in melanoma cells and the redistribution of N-cadherin to the heterotypic contacts. Transendothelial migration was inhibited when N-cadherin expression was repressed by antisense RNA, indicating a key role played by N-cadherin. Whereas N-cadherin and
-catenin colocalized in the contact regions between melanoma cells and endothelial cells during the initial stages of attachment,
-catenin disappeared from the heterotypic contacts during transmigration of melanoma cells. Immunolocalization and immunoprecipitation studies indicate that N-cadherin became tyrosine-phosphorylated, resulting in the dissociation of
-catenin from these contact regions. Concomitantly, an increase in the nuclear level of
-catenin occurred in melanoma cells, together with a sixfold increase in
-catenin-dependent transcription. Transendothelial migration was compromised in cells expressing a dominant-negative form of
-catenin, thus supporting a regulatory role of
-catenin signaling in this process.
Present address: Shandong Academy of Medical Sciences, Jinan 250062, Shandong Province, PR China.
Address correspondence to: Chi-Hung Siu (chi.hung.siu{at}utoronto.ca).
This article has been cited by other articles:
![]() |
H. Wessells, C. J. Sullivan, Y. Tsubota, K. L. Engel, B. Kim, N. E. Olson, D. Thorner, and K. Chitaley Transcriptional profiling of human cavernosal endothelial cells reveals distinctive cell adhesion phenotype and role for claudin 11 in vascular barrier function Physiol Genomics, October 7, 2009; 39(2): 100 - 108. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Drake, G. Strohbehn, T. B. Bair, J. G. Moreland, and M. D. Henry ZEB1 Enhances Transendothelial Migration and Represses the Epithelial Phenotype of Prostate Cancer Cells Mol. Biol. Cell, April 15, 2009; 20(8): 2207 - 2217. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. A. Kohutek, C. G. diPierro, G. T. Redpath, and I. M. Hussaini ADAM-10-Mediated N-Cadherin Cleavage Is Protein Kinase C-{alpha} Dependent and Promotes Glioblastoma Cell Migration J. Neurosci., April 8, 2009; 29(14): 4605 - 4615. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Massoumi, S. Kuphal, C. Hellerbrand, B. Haas, P. Wild, T. Spruss, A. Pfeifer, R. Fassler, and A. K. Bosserhoff Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma J. Exp. Med., January 16, 2009; 206(1): 221 - 232. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Augustine, Y. Yoshimoto, M. Gupta, P. A. Zipfel, M. A. Selim, P. Febbo, A. M. Pendergast, W. P. Peters, and D. S. Tyler Targeting N-Cadherin Enhances Antitumor Activity of Cytotoxic Therapies in Melanoma Treatment Cancer Res., May 15, 2008; 68(10): 3777 - 3784. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hulit, K. Suyama, S. Chung, R. Keren, G. Agiostratidou, W. Shan, X. Dong, T. M. Williams, M. P. Lisanti, K. Knudsen, et al. N-Cadherin Signaling Potentiates Mammary Tumor Metastasis via Enhanced Extracellular Signal-Regulated Kinase Activation Cancer Res., April 1, 2007; 67(7): 3106 - 3116. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Halbleib and W. J. Nelson Cadherins in development: cell adhesion, sorting, and tissue morphogenesis Genes & Dev., December 1, 2006; 20(23): 3199 - 3214. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Miller and M. C. Mihm Jr. Melanoma. N. Engl. J. Med., July 6, 2006; 355(1): 51 - 65. [Full Text] [PDF] |
||||
![]() |
C. W. Rinker-Schaeffer, J. P. O'Keefe, D. R. Welch, and D. Theodorescu Metastasis Suppressor Proteins: Discovery, Molecular Mechanisms, and Clinical Application. Clin. Cancer Res., July 1, 2006; 12(13): 3882 - 3889. [Full Text] [PDF] |
||||
![]() |
J. Qi, J. Wang, O. Romanyuk, and C.-H. Siu Involvement of Src Family Kinases in N-Cadherin Phosphorylation and beta-Catenin Dissociation during Transendothelial Migration of Melanoma Cells Mol. Biol. Cell, March 1, 2006; 17(3): 1261 - 1272. [Abstract] [Full Text] [PDF] |
||||